HEADER TOXIN 28-JUL-17 5WLX TITLE SOLUTION STRUCTURE OF KAPPA-THERAPHOTOXIN-AA1A COMPND MOL_ID: 1; COMPND 2 MOLECULE: KAPPA-THERAPHOTOXIN-AA1A; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: AVICULARIA; SOURCE 4 ORGANISM_TAXID: 446523 KEYWDS SPIDER TOXINS; INHIBITOR CYSTINE KNOT; THERAPHOTOXIN, TOXIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR Y.K.Y.CHIN,L.MA,G.F.KING REVDAT 3 14-JUN-23 5WLX 1 REMARK REVDAT 2 27-FEB-19 5WLX 1 JRNL REVDAT 1 01-AUG-18 5WLX 0 JRNL AUTH L.MA,Y.K.Y.CHIN,Z.DEKAN,V.HERZIG,C.Y.CHOW,J.HEIGHWAY, JRNL AUTH 2 S.W.LAM,G.J.GUILLEMIN,P.F.ALEWOOD,G.F.KING JRNL TITL NOVEL VENOM-DERIVED INHIBITORS OF THE HUMAN EAG CHANNEL, A JRNL TITL 2 PUTATIVE ANTIEPILEPTIC DRUG TARGET. JRNL REF BIOCHEM. PHARMACOL. V. 158 60 2018 JRNL REFN ISSN 1873-2968 JRNL PMID 30149017 JRNL DOI 10.1016/J.BCP.2018.08.038 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5WLX COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-JUL-17. REMARK 100 THE DEPOSITION ID IS D_1000229260. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 7.4 REMARK 210 IONIC STRENGTH : 20 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 1 MM KAPPA-THERAPHOTOXIN-AA1A, REMARK 210 20 MM SODIUM PHOSPHATE, 95% H2O/ REMARK 210 5% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-15N HSQC; 2D 1H-13C HSQC; REMARK 210 2D 1H-1H TOCSY; 2D 1H-1H NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : B REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA, ANALYSIS, TOPSPIN REMARK 210 METHOD USED : TORSION ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : BEST STEREOCHEMICAL PROPERTIES REMARK 210 AS JUDGED BY MOLPROBITY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 CYS A 18 -175.28 -69.91 REMARK 500 1 CYS A 23 104.72 -53.15 REMARK 500 1 TRP A 29 141.48 -171.12 REMARK 500 2 CYS A 18 -175.17 -69.80 REMARK 500 2 CYS A 23 104.65 -52.99 REMARK 500 2 TRP A 29 141.45 -171.60 REMARK 500 3 PRO A 16 -171.62 -69.77 REMARK 500 3 CYS A 18 -174.97 -69.82 REMARK 500 3 CYS A 23 104.68 -51.92 REMARK 500 3 TRP A 29 142.17 -170.63 REMARK 500 4 PRO A 16 -173.77 -69.72 REMARK 500 4 CYS A 18 -174.69 -69.95 REMARK 500 4 CYS A 23 104.69 -51.80 REMARK 500 4 TRP A 29 141.86 -171.60 REMARK 500 5 PRO A 16 -174.46 -69.76 REMARK 500 5 CYS A 18 -174.62 -69.98 REMARK 500 5 CYS A 23 104.73 -52.17 REMARK 500 5 TRP A 29 141.52 -170.86 REMARK 500 6 PRO A 16 -174.07 -69.72 REMARK 500 6 CYS A 18 -174.68 -69.97 REMARK 500 6 CYS A 23 104.71 -51.96 REMARK 500 6 TRP A 29 141.55 -171.19 REMARK 500 7 PRO A 16 -171.13 -69.71 REMARK 500 7 CYS A 18 -174.63 -69.88 REMARK 500 7 CYS A 23 104.78 -51.94 REMARK 500 7 TRP A 29 141.83 -171.72 REMARK 500 8 LYS A 14 56.35 -99.05 REMARK 500 8 CYS A 18 -175.37 -69.89 REMARK 500 8 CYS A 23 104.61 -53.85 REMARK 500 8 TRP A 29 141.52 -170.58 REMARK 500 9 PRO A 16 -173.68 -69.78 REMARK 500 9 CYS A 18 -174.74 -69.95 REMARK 500 9 CYS A 23 104.66 -51.81 REMARK 500 9 TRP A 29 141.57 -171.72 REMARK 500 10 PRO A 16 -174.25 -69.68 REMARK 500 10 CYS A 23 104.73 -51.83 REMARK 500 10 TRP A 29 141.07 -170.91 REMARK 500 11 PRO A 16 -173.23 -69.82 REMARK 500 11 CYS A 18 -174.86 -69.92 REMARK 500 11 CYS A 23 104.69 -51.89 REMARK 500 11 TRP A 29 142.02 -171.14 REMARK 500 12 LYS A 14 48.36 -99.17 REMARK 500 12 PRO A 16 -176.88 -69.68 REMARK 500 12 CYS A 18 -175.40 -69.93 REMARK 500 12 CYS A 23 104.78 -54.23 REMARK 500 12 TRP A 29 141.62 -171.65 REMARK 500 12 ASP A 33 129.51 -170.72 REMARK 500 13 PRO A 16 -174.53 -69.72 REMARK 500 13 CYS A 18 -174.73 -69.95 REMARK 500 13 CYS A 23 104.71 -51.86 REMARK 500 REMARK 500 THIS ENTRY HAS 79 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30318 RELATED DB: BMRB REMARK 900 SOLUTION STRUCTURE OF KAPPA-THERAPHOTOXIN-AA1A DBREF 5WLX A 1 37 PDB 5WLX 5WLX 1 37 SEQRES 1 A 37 GLY ASP CYS HIS LYS PHE LEU GLY TRP CYS ARG GLY GLU SEQRES 2 A 37 LYS ASP PRO CYS CYS GLU HIS LEU THR CYS HIS VAL LYS SEQRES 3 A 37 HIS GLY TRP CYS VAL TRP ASP GLY THR ILE NH2 HET NH2 A 37 3 HETNAM NH2 AMINO GROUP FORMUL 1 NH2 H2 N SHEET 1 AA1 2 LEU A 21 THR A 22 0 SHEET 2 AA1 2 VAL A 31 TRP A 32 -1 O VAL A 31 N THR A 22 SSBOND 1 CYS A 3 CYS A 18 1555 1555 2.00 SSBOND 2 CYS A 10 CYS A 23 1555 1555 2.00 SSBOND 3 CYS A 17 CYS A 30 1555 1555 2.00 LINK C ILE A 36 N NH2 A 37 1555 1555 1.33 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1